<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1239" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1239/" /><meta name="ncbi_pagename" content="Milroy Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Milroy Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Milroy Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/09/25" /><meta name="citation_author" content="Glen W Brice" /><meta name="citation_author" content="Sahar Mansour" /><meta name="citation_author" content="Pia Ostergaard" /><meta name="citation_author" content="Fiona Connell" /><meta name="citation_author" content="Steve Jeffery" /><meta name="citation_author" content="Peter Mortimer" /><meta name="citation_pmid" content="20301417" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1239/" /><meta name="citation_keywords" content="Hereditary Lymphedema, Type I" /><meta name="citation_keywords" content="Milroy Congenital Lymphedema" /><meta name="citation_keywords" content="Hereditary Lymphedema, Type I" /><meta name="citation_keywords" content="Milroy Congenital Lymphedema" /><meta name="citation_keywords" content="Vascular endothelial growth factor receptor 3" /><meta name="citation_keywords" content="FLT4" /><meta name="citation_keywords" content="Milroy Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Milroy Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Glen W Brice" /><meta name="DC.Contributor" content="Sahar Mansour" /><meta name="DC.Contributor" content="Pia Ostergaard" /><meta name="DC.Contributor" content="Fiona Connell" /><meta name="DC.Contributor" content="Steve Jeffery" /><meta name="DC.Contributor" content="Peter Mortimer" /><meta name="DC.Date" content="2014/09/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1239/" /><meta name="description" content="Milroy disease is characterized by lower-limb lymphedema, present as pedal edema at (or before) birth or developing soon after. Occasionally it develops later in life. The severity of edema shows both inter- and intrafamilial variability. Swelling is usually bilateral but can be asymmetric. The degree of edema can progress but in some instances can improve, particularly in early years. Other features sometimes associated with Milroy disease include hydrocele (37% of males), prominent veins (23%), upslanting toenails (14%), papillomatosis (10%), and urethral abnormalities in males (4%). Cellulitis, which can damage the lymphatic vessels, occurs in approximately 20% of affected individuals, with infection significantly more likely in males than females." /><meta name="og:title" content="Milroy Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Milroy disease is characterized by lower-limb lymphedema, present as pedal edema at (or before) birth or developing soon after. Occasionally it develops later in life. The severity of edema shows both inter- and intrafamilial variability. Swelling is usually bilateral but can be asymmetric. The degree of edema can progress but in some instances can improve, particularly in early years. Other features sometimes associated with Milroy disease include hydrocele (37% of males), prominent veins (23%), upslanting toenails (14%), papillomatosis (10%), and urethral abnormalities in males (4%). Cellulitis, which can damage the lymphatic vessels, occurs in approximately 20% of affected individuals, with infection significantly more likely in males than females." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1239/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/milroy/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1239/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BB8AEE041453100000000009C003B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1239_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1239_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/anophthalmia-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kss/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1239_"><span class="title" itemprop="name">Milroy Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Hereditary Lymphedema, Type I; Milroy Congenital Lymphedema</div><p class="contrib-group"><span itemprop="author">Glen W Brice</span>, RGN BSc (Hons), <span itemprop="author">Sahar Mansour</span>, FRCP, <span itemprop="author">Pia Ostergaard</span>, PhD, <span itemprop="author">Fiona Connell</span>, MBChB, MRCPCH, MD, <span itemprop="author">Steve Jeffery</span>, PhD, and <span itemprop="author">Peter Mortimer</span>, MD, FRCP.</p><a data-jig="ncbitoggler" href="#__NBK1239_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1239_ai__"><div class="contrib half_rhythm"><span itemprop="author">Glen W Brice</span>, RGN BSc (Hons)<div class="affiliation small">SW Thames Regional Genetics Department<br />St George's, University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@ecirbg" class="oemail">ku.ca.lugs@ecirbg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sahar Mansour</span>, FRCP<div class="affiliation small">Consultant Geneticist, SW Thames Regional Genetics Department<br />St George's, University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@ruosnams" class="oemail">ku.ca.lugs@ruosnams</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Pia Ostergaard</span>, PhD<div class="affiliation small">Medical Genetics Unit, Clinical Developmental Sciences<br />St George's, University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@agretsop" class="oemail">ku.ca.lugs@agretsop</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fiona Connell</span>, MBChB, MRCPCH, MD<div class="affiliation small">Guy's Genetics Service<br />Guy's Hospital<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.oc.ttsg@llennoc.anoif" class="oemail">ku.oc.ttsg@llennoc.anoif</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Steve Jeffery</span>, PhD<div class="affiliation small">Medical Genetics Unit, Clinical Developmental Sciences<br />St George's, University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@001tggs" class="oemail">ku.ca.lugs@001tggs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Peter Mortimer</span>, MD, FRCP<div class="affiliation small">Department of Cardiac and Vascular Sciences (Dermatology)<br />St George's, University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@remitrom" class="oemail">ku.ca.lugs@remitrom</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 27, 2006</span>; Last Update: <span itemprop="dateModified">September 25, 2014</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="milroy.Summary" itemprop="description"><h2 id="_milroy_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Milroy disease is characterized by lower-limb lymphedema, present as pedal edema at (or before) birth or developing soon after. Occasionally it develops later in life. The severity of edema shows both inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>. Swelling is usually bilateral but can be asymmetric. The degree of edema can progress but in some instances can improve, particularly in early years. Other features sometimes associated with Milroy disease include hydrocele (37% of males), prominent veins (23%), upslanting toenails (14%), papillomatosis (10%), and urethral abnormalities in males (4%). Cellulitis, which can damage the lymphatic vessels, occurs in approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, with infection significantly more likely in males than females.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Milroy disease is diagnosed by clinical findings and confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Lymphoscintigraphy can be performed; the characteristic finding is lack of uptake of radioactive colloid in the ilioinguinal lymph nodes caused by a paucity of lymphatic vessels or abnormal function of the vessels in the lower limbs. <i>FLT4</i>
<i>(VEGFR3</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with Milroy disease.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> A lymphedema therapist may utilize fitted stockings and massage to improve the cosmetic appearance or decrease the size of the limb and reduce the risk of complications. Improvement in swelling is usually possible with use of properly fitted compression hosiery and/or bandaging and well-fitting, supportive shoes. Toe gloves may be of benefit and good skin care is essential.</p><p><i>Prevention of secondary complications:</i> Frequency of cellulitis can be reduced through good skin hygiene, prompt treatment of infections with antibiotics, and prophylactic antibiotics for recurrent episodes.</p><p><i>Agents/circumstances to avoid</i>: Wounds to limbs; long periods of immobility with the legs in a dependent position; and medications that can cause increased leg swelling.</p><p><i>Evaluation of relatives at risk</i>: Evaluating relatives at risk ensures identification of those who will benefit from treatment early in the disease course.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Milroy disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an individual with Milroy disease has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation has been reported, the proportion of cases caused by <i>de novo</i> pathogenic variants is not known. Ultrasonography during pregnancy may detect swelling of the dorsum of the feet, mild pleural effusions which often resolve and (very rarely) more extensive edematous states (hydrops fetalis) in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus. Prenatal testing is possible for pregnancies at increased risk if the pathogenic variant in the family is known; however, it is rarely requested.</p></div></div><div id="milroy.Diagnosis"><h2 id="_milroy_Diagnosis_">Diagnosis</h2><div id="milroy.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Milroy disease <b>should be suspected</b> in individuals with the following findings:</p><ul><li class="half_rhythm"><div>Lower-limb swelling that is:</div><ul><li class="half_rhythm"><div class="half_rhythm">Usually but not always bilateral</div></li><li class="half_rhythm"><div class="half_rhythm">Present at birth or develops soon after</div><div class="half_rhythm">Note: In neonates the swelling predominantly affects the dorsum of the feet; with age, the swelling may improve or progress to affect the whole lower leg.</div></li></ul></li><li class="half_rhythm"><div>Large-caliber veins</div></li><li class="half_rhythm"><div>Upslanting, "ski-jump" toenails</div></li></ul><p>Evaluation of the limb swelling can include lymphoscintigraphy<b>.</b> Radioactive colloid is injected into the toe web spaces and uptake in the ilioinguinal nodes is measured at intervals. Lymphoscintigraphy is performed to determine if there is lack of uptake of radioactive tracer. This can help with the diagnosis of Milroy disease as other forms of lymphedema can have differing patterns on lymphoscintigraphy [<a class="bk_pop" href="#milroy.REF.connell.2013.303">Connell et al 2013</a>]. In cases of unilateral swelling, lymphoscintigraphy can determine if lymphatic drainage is impaired in the "unaffected" leg.</p><p>Note: (1) Lymphoscintigraphy normally replaces lymphangiography (x-ray after direct injection of dye into the lymphatic vessels in the foot) as it is less invasive. (2) Lymphangiography is also technically more problematic because of difficulties locating lymphatic vessels for cannulation.</p><p>Lymphoscintigraphy is not essential to make the diagnosis and one can proceed directly to molecular testing.</p></div><div id="milroy.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Milroy disease <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLT4</i> (<i>VEGFR3</i>), the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with Milroy disease [<a class="bk_pop" href="#milroy.REF.ferrell.1998.2073">Ferrell et al 1998</a>, <a class="bk_pop" href="#milroy.REF.irrthum.2000.295">Irrthum et al 2000</a>, <a class="bk_pop" href="#milroy.REF.karkkainen.2000.153">Karkkainen et al 2000</a>, <a class="bk_pop" href="#milroy.REF.evans.2003.697">Evans et al 2003</a>] (see <a class="figpopup" href="/books/NBK1239/table/milroy.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figmilroyTmoleculargenetictestingused" rid-ob="figobmilroyTmoleculargenetictestingused">Table 1</a>).</p><p><b>One genetic testing strategy</b> is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>FLT4</i> by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of exons 17 to 26.</p><p><b>An alternative genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>FLT4</i> and other genes of interest (see <a href="#milroy.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="milroy.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Milroy Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1239/table/milroy.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__milroy.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLT4</i></td><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;75% in well-phenotyped cohorts&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>4</sup></td><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_milroy.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="milroy.TF.1.1"><p class="no_margin">See <a href="/books/NBK1239/#milroy.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#milroy.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="milroy.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="milroy.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#milroy.REF.connell.2009.625">Connell et al [2009]</a> suggest that a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is detected in 75% of those clearly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and with a positive family history and in 68% of those with typical Milroy features but without a family history.</p></div></dd><dt>4. </dt><dd><div id="milroy.TF.1.4"><p class="no_margin">No other loci have been identified, but reports suggest that Milroy disease is genetically heterogeneous [<a class="bk_pop" href="#milroy.REF.holberg.2001.303">Holberg et al 2001</a>, <a class="bk_pop" href="#milroy.REF.evans.2003.697">Evans et al 2003</a>]. Even when the individual has a clear clinical diagnosis, an <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found in only 75% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, suggesting that other genes may be involved [<a class="bk_pop" href="#milroy.REF.connell.2009.625">Connell et al 2009</a>]. Rare cases may be caused by pathogenic variants in <i>VEGFC</i> [<a class="bk_pop" href="#milroy.REF.gordon.2013a.956">Gordon et al 2013a</a>].</p></div></dd></dl></div></div></div></div></div><div id="milroy.Clinical_Characteristics"><h2 id="_milroy_Clinical_Characteristics_">Clinical Characteristics</h2><div id="milroy.Clinical_Description"><h3>Clinical Description</h3><p>The most common finding in Milroy disease is lower-limb lymphedema. The edema is usually present from (or before) birth. In neonates the swelling tends to affect primarily the dorsum of the feet. Anecdotal evidence suggests that on rare occasions it develops later in life.</p><p>The amount of edema varies both within and among families. Swelling is often bilateral, but can be asymmetric.</p><p>The degree of edema sometimes progresses but in some instances can improve, particularly in early years.</p><p>Other features sometimes associated with Milroy disease include:</p><ul><li class="half_rhythm"><div>Hydrocele (37% of males)</div></li><li class="half_rhythm"><div>Prominent veins (23%)</div></li><li class="half_rhythm"><div>Upslanting toenails (14%)</div></li><li class="half_rhythm"><div>Papillomatosis (10%)</div></li><li class="half_rhythm"><div>Urethral abnormalities in males (4%)</div></li></ul><p>Cellulitis occurs in approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, with infection significantly more likely in males than females [<a class="bk_pop" href="#milroy.REF.brice.2005.98">Brice et al 2005</a>]. Cellulitis can damage the existing lymphatic vessels, resulting in an increase in the degree of swelling.</p><p>Rarely, prenatal pleural effusion and hydrops fetalis have been reported [<a class="bk_pop" href="#milroy.REF.danielspiegel.2005.1015">Daniel-Spiegel et al 2005</a>], but in general Milroy disease is not associated with more widespread lymphatic abnormalities.</p></div><div id="milroy.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been reported.</p><p>Intra- and interfamilial variation in the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is wide.</p></div><div id="milroy.Penetrance"><h3>Penetrance</h3><p>Approximately 85%-90% of individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLT4</i> develop lower-limb lymphedema by age three years; conversely, 10%-15% of individuals with an <i>FLT4</i> pathogenic variant are clinically unaffected.</p></div><div id="milroy.Anticipation"><h3>Anticipation</h3><p>Anticipation has not been observed.</p></div><div id="milroy.Nomenclature"><h3>Nomenclature</h3><p>Milroy disease is named after William Milroy, who described 97 members of a family, of whom 26 had leg edema [<a class="bk_pop" href="#milroy.REF.milroy.1892.505">Milroy 1892</a>]. In the family described by Milroy, the edema was painless, non-progressive, and confined to the lower limbs.</p><p>Hereditary lymphedema of the legs was also described by <a class="bk_pop" href="#milroy.REF.nonne.1891">Nonne [1891]</a>; hence, the term Nonne-Milroy disease has been used in the past.</p></div><div id="milroy.Prevalence"><h3>Prevalence</h3><p>The prevalence of Milroy disease is not known but it appears to be one of the more common causes of primary lymphedema and occurs in all ethnic groups.</p></div></div><div id="milroy.Genetically_Related_Allelic_Disor"><h2 id="_milroy_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>FLT4</i>.</p></div><div id="milroy.Differential_Diagnosis"><h2 id="_milroy_Differential_Diagnosis_">Differential Diagnosis</h2><p>Milroy disease is suspected in individuals with "woody" swelling of the dorsum of the feet with few associated features. Family history, if present, is consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance.</p><p>A list of differential diagnoses can be found in <a class="bk_pop" href="#milroy.REF.connell.2013.303">Connell et al [2013]</a>.</p><p><b>Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR)</b> (OMIM <a href="http://omim.org/entry/152950" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">152950</a>). This <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition is caused by mutation of <i>KIF11</i>. The edema seen in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KIF11</i> is indistinguishable from that associated with <i>FLT4</i> pathogenic variants. Features associated with <i>KIF11</i> pathogenic variants (and not seen in Milroy disease) include microcephaly, chorioretinopathy, and (in most individuals) learning difficulties. However, the pattern on lymphoscintigraphy in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is identical for the two disorders [<a class="bk_pop" href="#milroy.REF.ostergaard.2012.356">Ostergaard et al 2012</a>, <a class="bk_pop" href="#milroy.REF.jones.2014.881">Jones et al 2014</a>].</p><p><b><i>VEGFC</i>-related lymphoedema.</b> Two families with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resembling Milroy disease have been shown to have pathogenic variants in <i>VEGFC</i>. Clinically, it is not possible to distinguish these individuals from those with <i>FLT4</i> pathogenic variants and testing of <i>VEGFC</i> should be considered if <i>FLT4</i> testing is negative. The pattern on lymphoscintigraphy in individuals with <i>VEGFC</i> pathogenic variants is different from that in patients with Milroy disease [<a class="bk_pop" href="#milroy.REF.gordon.2013a.956">Gordon et al 2013a</a>].</p><p>Other disorders in the differential diagnosis may be distinguished by age of onset.</p><p><b>Turner syndrome</b> is the combination of a characteristic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in females who have one normal X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> and either (1) absence of the second sex chromosome (X or Y) with or without <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> or (2) partial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the X chromosome. The Turner syndrome phenotype includes short stature, stature disproportion, primary amenorrhea, neck webbing, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lymphedema of the hands and feet, high-arched palate, short metacarpals, scoliosis, Madelung deformity, hearing difficulties, cardiac and renal anomalies, hypothyroidism, and glucose intolerance [<a class="bk_pop" href="#milroy.REF.batch.2002.465">Batch 2002</a>, <a class="bk_pop" href="#milroy.REF.sybert.2004.1227">Sybert &#x00026; McCauley 2004</a>]. Lymphedema in this syndrome affects the extremities and often improves over time. Turner syndrome occurs in 1:2500 to 1:3000 live female births [<a class="bk_pop" href="#milroy.REF.sybert.2004.1227">Sybert &#x00026; McCauley 2004</a>] and should always be considered in a female with congenital lymphedema particularly if hands and feet are affected.</p><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a> is characterized by short stature, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect, and developmental delay of variable degree. Other findings can include broad or webbed neck, unusual chest shape with superior pectus carinatum and inferior pectus excavatum, cryptorchidism, and characteristic facies. Varied coagulation defects and lymphatic dysplasias are observed with onset at birth or in childhood. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of individuals. Hypertrophic cardiomyopathy, found in 20%-30% of individuals, may be present at birth or appear in infancy or childhood. Pathogenic variants in <i>PTPN11</i> are observed in 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <i>SOS1</i> in approximately 13%, <i>RAF1</i> in 3%-17%, and <i>KRAS</i> in fewer than 5%. Other genes in which pathogenic variants have been reported to cause Noonan syndrome in fewer than 1% of cases include <i>NRAS</i>, <i>BRAF</i>, and <i>MAP2K1</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>. People with Noonan syndrome may present with congenital lymphedema of the feet and legs. They may also present later with lower-limb and genital edema, chylous reflux, intestinal lymphangiectasia, and/or chylothoraces.</p><p><b>Hypotrichosis-lymphedema-telangiectasia syndrome</b> (OMIM <a href="http://omim.org/entry/607823" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607823</a>) is the association of childhood-onset lymphedema in the lower limbs, loss of hair, and telangiectasia, particularly on the palms. Inheritance is either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>. Pathogenic variants in <i>SOX18</i> are causative [<a class="bk_pop" href="#milroy.REF.irrthum.2003.1470">Irrthum et al 2003</a>].</p><p><a href="/books/n/gene/lds/"><b>Lymphedema-distichiasis syndrome</b></a> is characterized by lower-limb lymphedema and distichiasis. Lymphedema typically appears in late childhood or puberty, is confined to the lower limbs, and is often asymmetric; severity varies within families. Males develop edema at an earlier age and have more problems with cellulitis than females. Distichiasis, which may be present at birth and is observed in 94% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, describes the presence of aberrant eyelashes arising from the Meibomian glands ranging from a full set of extra eyelashes to a single hair. About 75% of affected individuals have ocular findings resulting from the aberrant eyelashes including corneal irritation, recurrent conjunctivitis, and photophobia; other common findings include early-onset varicose veins (50%), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease (7%), and ptosis (30%). About 25% of individuals are asymptomatic. <i>FOXC2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with lymphedema-distichiasis syndrome. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Meige disease</b> (OMIM <a href="http://omim.org/entry/153200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">153200</a>) presents with pubertal-onset lymphedema. No other features appear to be associated. Women are more commonly affected than men. No genes have been identified as yet. Inheritance appears to be <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Lymphedema with yellow nails</b> (yellow nail syndrome, YNS) (OMIM <a href="http://omim.org/entry/153300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">153300</a>) often presents after age 50 years. The nails in YNS are very slow growing, with transverse over-curvature and hardening of the nail plate. The nail changes are different from the typically discolored nails that are often associated with chronic lymphedema of any cause. Inheritance is said to be <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; however, most cases are not associated with a family history [<a class="bk_pop" href="#milroy.REF.hoque.2007.1230">Hoque et al 2007</a>, <a class="bk_pop" href="#milroy.REF.maldonado.2008.375">Maldonado et al 2008</a>].</p></div><div id="milroy.Management"><h2 id="_milroy_Management_">Management</h2><div id="milroy.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Milroy disease, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li><li class="half_rhythm"><div>Referral to a lymphedema therapist</div></li><li class="half_rhythm"><div>Lymphoscintigraphy</div></li></ul></div><div id="milroy.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Guidance by a lymphedema therapist regarding management of edema (e.g., fitting stockings, massage) is important. Although the edema cannot be cured, some improvement is usually possible with the use of properly fitted compression hosiery and/or bandaging and well fitting, supportive shoes. Toe gloves may be of benefit and good skin care is essential. Such treatment measures may improve the cosmetic appearance of the limb, decrease the size of the limb, and reduce the risk of complications.</p></div><div id="milroy.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p>Secondary cellulitis is prevented through the following measures:</p><ul><li class="half_rhythm"><div>Prevention of foot infections, particularly athlete's foot/infected eczema</div></li><li class="half_rhythm"><div>Prompt treatment for early cellulitis with appropriate antibiotics. It may be necessary to give the first few doses intravenously.</div></li><li class="half_rhythm"><div>Prophylactic antibiotics in recurrent cases (e.g., penicillin V 500 mg daily)</div></li></ul></div><div id="milroy.Surveillance"><h3>Surveillance</h3><p>Routine follow up in a clinic specializing in the care of lymphedema is appropriate.</p></div><div id="milroy.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Wounds to the swollen limbs, because of their reduced resistance to infection</div></li><li class="half_rhythm"><div>Long periods of immobility with the legs in a dependent position (e.g., on a long airplane flight)</div></li><li class="half_rhythm"><div>Medications, particularly calcium channel-blocking drugs, that can cause increased leg swelling in some individuals</div></li></ul></div><div id="milroy.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If the <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk relatives ensures identification of those who will benefit from treatment early in the disease course.</p><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a family is not known, evaluation of relatives at risk by physical examination is appropriate in order to identify those who will benefit from treatment early in the course of the disease. The use of properly fitted compression hosiery and advice to reduce the risk of cellulitis of the legs and feet can be beneficial.</p><p>See <a href="#milroy.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="milroy.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Ultrasound scanning during pregnancy may indicate if a fetus is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> if swelling of the dorsum of the feet is noted in the second or third trimester. The fetus may have mild pleural effusions which frequently resolve before birth [S Mansour, personal communication]. Very rarely, the fetus may present with hydrops fetalis. If the mother is affected by Milroy disease there may be an increase in swelling during the pregnancy.</p></div><div id="milroy.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Attempts at overexpressing VEGF-C, the ligand for <i>FLT4</i>, have been successful in producing functional lymphatics in mice [<a class="bk_pop" href="#milroy.REF.karkkainen.2001.12677">Karkkainen et al 2001</a>]. This is now in clinical trial in Finland for human breast cancer-related lymphedema.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>ClinicalTrials.gov</u></a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="milroy.Other"><h3>Other</h3><p>Treatment with diuretics is of no proven benefit.</p></div></div><div id="milroy.Genetic_Counseling"><h2 id="_milroy_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="milroy.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Milroy disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="milroy.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with Milroy disease have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Milroy disease may have the disorder as the result of a <i>de novo FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is not presently known, as a clinical delineator for Milroy disease has, in the past, included a family history of the disorder. Of the 15 pathogenic variants discovered in the authors' laboratory to date (7 of these unpublished data), three represent <i>de novo</i> pathogenic variants [<a class="bk_pop" href="#milroy.REF.carver.2007.187">Carver et al 2007</a>]. Previously, one <i>de novo</i> pathogenic variant was reported [<a class="bk_pop" href="#milroy.REF.ghalamkarpour.2006.330">Ghalamkarpour et al 2006</a>].</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Germline mosaicism has been observed [Author, personal communication] but remains uncommon.</div></li></ul><p>Note: Although most individuals diagnosed with Milroy disease have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members as a result of variable expression or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for pathogenic variants in <i>FLT4</i> is rare but has occurred [Author, personal communication].</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has an <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low, but greater than that of the general population because of the possibilities of non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with Milroy disease has a 50% chance of inheriting the <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="milroy.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#milroy.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="milroy.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>FLT4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diganosis are possible.</p><p><b>Ultrasound examination.</b> Ultrasonography during pregnancy may detect swelling of the dorsum of the feet, mild pleural effusions which often resolve, and (very rarely) more extensive edematous states (hydrops fetalis) in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus [<a class="bk_pop" href="#milroy.REF.franceschini.2001.182">Franceschini et al 2001</a>, <a class="bk_pop" href="#milroy.REF.makhoul.2002.823">Makhoul et al 2002</a>, <a class="bk_pop" href="#milroy.REF.danielspiegel.2005.1015">Daniel-Spiegel et al 2005</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="milroy.Resources"><h2 id="_milroy_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Lymphoedema Support Network (LSN)</b></div><div>St. Luke's Crypt</div><div>Sydney Street</div><div>London SW3 6NH</div><div>United Kingdom</div><div><b>Phone:</b> 020 7351 4480 (Information and Support); 020 7351 0990 (Administration)</div><div><b>Fax:</b> 020 7349 9809</div><div><b>Email:</b> adminlsn@lymphoedema.freeserve.co.uk</div><div><a href="http://www.lymphoedema.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lymphoedema.org</a></div></li><li class="half_rhythm"><div><b>National Lymphedema Network (NLN)</b></div><div>116 New Montgomery Street</div><div>Suite 235</div><div>San Francisco CA 94105</div><div><b>Phone:</b> 800-541-3259 (toll-free); 415-908-3681</div><div><b>Fax:</b> 415-908-3813</div><div><b>Email:</b> nln@lymphnet.org</div><div><a href="http://www.lymphnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lymphnet.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/lymphaticdiseases.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lymphatic diseases</a></div></li><li class="half_rhythm"><div><b>Lymphedema Family Study</b></div><div>University of Pittsburgh, Department of Human Genetics</div><div>A300 Crabtree Hall, GSPH</div><div>Pittsburgh PA 15261</div><div><b>Phone:</b> 800-263-2152 (toll-free); 412-624-4659</div><div><b>Email:</b> genetics@pitt.edu</div></li></ul></div><div id="milroy.Molecular_Genetics"><h2 id="_milroy_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="milroy.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Milroy Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1239/table/milroy.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__milroy.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_milroy.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_milroy.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_milroy.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_milroy.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_milroy.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_milroy.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_milroy.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2324" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLT4</i></a></td><td headers="hd_b_milroy.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2324" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q35<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_milroy.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35916" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vascular endothelial growth factor receptor 3</a></td><td headers="hd_b_milroy.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FLT4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLT4 database</a></td><td headers="hd_b_milroy.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLT4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLT4</a></td><td headers="hd_b_milroy.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLT4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLT4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="milroy.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="milroy.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Milroy Disease (<a href="/omim/136352,153100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1239/table/milroy.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__milroy.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/136352" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">136352</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FMS-LIKE TYROSINE KINASE 4; FLT4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/153100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">153100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LYMPHATIC MALFORMATION 1; LMPHM1</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is about 45 kb in length; it has 31 exons and two mRNAs of 4.5 kb and 5.8 kb, the latter being the more predominant species. For a detailed summary of gene and protein information, see <a href="/books/NBK1239/#milroy.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Normal variants include the following:</p><ul><li class="half_rhythm"><div>p.Pro641Ser, p.Asn199Asp, p.Thr494Ala, p.Gln890His, p.Pro954Ser, p.Pro1008Leu, p.Arg1146His, p.Arg1342Leu</div></li><li class="half_rhythm"><div>c.507G&#x0003e;T, c.3198T&#x0003e;C (silent); 17 <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> polymorphisms are detailed in <a class="bk_pop" href="#milroy.REF.iljin.2001.1028">Iljin et al [2001]</a>.</div></li></ul><p><b>Pathogenic variants.</b> All pathogenic variants identified to date have been in exons encoding tyrosine kinase domains. Identification of pathogenic variants only in these exons may in part be the result of a bias in ascertainment; however, <a class="bk_pop" href="#milroy.REF.connell.2009.625">Connell et al [2009]</a> screened all exons of <i>FLT4</i> and did not find any pathogenic variants outside the tyrosine kinase domains. See <a class="bk_pop" href="#milroy.REF.gordon.2013b.23">Gordon et al [2013b]</a> for discussion of variants reported in the literature.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal gene product, VEGFR-3 (vascular endothelial growth factor receptor 3), is a dimeric receptor for the ligands VEGFC and VEGFD. VEGFR-3 is a lymphatic endothelial cell-specific receptor tyrosine kinase.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The abnormal gene products are either mutant/mutant type homodimers showing no tyrosine kinase activity or mutant/wild type heterodimers showing some TK activity [<a class="bk_pop" href="#milroy.REF.irrthum.2000.295">Irrthum et al 2000</a>, <a class="bk_pop" href="#milroy.REF.karkkainen.2000.153">Karkkainen et al 2000</a>]. However, the only pathogenic variants to have been tested in this way are p.Gly857Arg, p.His1035Arg, p.Arg1041Pro, p.Leu1044Pro, and p.Pro1114Leu.</p></div><div id="milroy.References"><h2 id="_milroy_References_">References</h2><div id="milroy.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.batch.2002.465">Batch J. Turner syndrome in childhood and adolescence. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2002;<span class="ref-vol">16</span>:465–82.</span> [<a href="/pubmed/12464229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12464229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.brice.2005.98">Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S, Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:98–102.</span> [<a href="/pmc/articles/PMC1735984/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735984</span></a>] [<a href="/pubmed/15689446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.carver.2007.187">Carver C, Brice G, Mansour S, Ostergaard P, Mortimer P, Jeffery S. Three children with Milroy disease and de novo mutations in VEGFR3. <span><span class="ref-journal">Clin Genet. </span>2007;<span class="ref-vol">71</span>:187–9.</span> [<a href="/pubmed/17250670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17250670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.connell.2013.303">Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, Mansour S, Ostergaard P. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:303–14.</span> [<a href="/pubmed/23621851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23621851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.connell.2009.625">Connell FC, Ostergaard P, Carver C, Brice G, Williams N, Mansour S, Mortimer PS, Jeffery S, et al.  Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. <span><span class="ref-journal">Hum Genet. </span>2009;<span class="ref-vol">124</span>:625–31.</span> [<a href="/pubmed/19002718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19002718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.danielspiegel.2005.1015">Daniel-Spiegel E, Ghalamkarpour A, Spiegel R, Weiner E, Vikkula M, Shalev E, Shalev SA. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. <span><span class="ref-journal">Prenat Diagn. </span>2005;<span class="ref-vol">25</span>:1015–8.</span> [<a href="/pubmed/16231305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16231305</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.evans.2003.697">Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M, Child AH. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:697–703.</span> [<a href="/pmc/articles/PMC1735587/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735587</span></a>] [<a href="/pubmed/12960217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12960217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.ferrell.1998.2073">Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, Finegold DN. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:2073–8.</span> [<a href="/pubmed/9817924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9817924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.franceschini.2001.182">Franceschini P, Licata D, Rapello G, Guala A, Di Cara G, Franceschini D. Prenatal diagnosis of Nonne-Milroy lymphedema. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2001;<span class="ref-vol">18</span>:182–3.</span> [<a href="/pubmed/11547763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11547763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.ghalamkarpour.2006.330">Ghalamkarpour A, Morlot S, Raas-Rothschild A, Utkus A, Mulliken JB, Boon LM, Vikkula M. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">70</span>:330–5.</span> [<a href="/pubmed/16965327" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16965327</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.gordon.2013a.956">Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, Mansour S, Schulte-Merker S, Ostergaard P. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant Milroy-like primary lymphedema. <span><span class="ref-journal">Circ Res. </span>2013a;<span class="ref-vol">112</span>:956–60.</span> [<a href="/pubmed/23410910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23410910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.gordon.2013b.23">Gordon K, Spiden SL, Connell FC, Brice G, Cottrell S, Short J, Taylor R, Jeffery S, Mortimer PS, Mansour S, Ostergaard P. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. <span><span class="ref-journal">Hum Mutat. </span>2013b;<span class="ref-vol">34</span>:23–31.</span> [<a href="/pubmed/23074044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23074044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.holberg.2001.303">Holberg CJ, Erickson RP, Bernas MJ, Witte MH, Fultz KE, Andrade M, Witte CL. Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">98</span>:303–12.</span> [<a href="/pubmed/11170072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11170072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.hoque.2007.1230">Hoque SR, Mansour S, Mortimer PS. Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature. <span><span class="ref-journal">Br J Dermatol. </span>2007;<span class="ref-vol">156</span>:1230–4.</span> [<a href="/pubmed/17459037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17459037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.iljin.2001.1028">Iljin K, Karkkainen MJ, Lawrence EC, Kimak MA, Uutela M, Taipale J, Pajusola K, Alhonen L, Halmekyto M, Finegold DN, Ferrell RE, Alitalo K. VEGFR3 gene structure, regulatory region, and sequence polymorphisms. <span><span class="ref-journal">FASEB J. </span>2001;<span class="ref-vol">15</span>:1028–36.</span> [<a href="/pubmed/11292664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11292664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.irrthum.2003.1470">Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns JP, Van Steensel MA, Vikkula M. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1470–8.</span> [<a href="/pmc/articles/PMC1180307/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180307</span></a>] [<a href="/pubmed/12740761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12740761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.irrthum.2000.295">Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:295–301.</span> [<a href="/pmc/articles/PMC1287178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287178</span></a>] [<a href="/pubmed/10856194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10856194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.jones.2014.881">Jones GE, Ostergaard P, Moore AT, Connell FC, Williams D, Quarrell O, Brady AF, Spier I, Hazan F, Moldovan O, Wieczorek D, Mikat B, Petit F, Coubes C, Saul RA, Brice G, Gordon K, Jeffery S, Mortimer PS, Vasudevan PC, Mansour S. Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:881–7.</span> [<a href="/pmc/articles/PMC3938398/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3938398</span></a>] [<a href="/pubmed/24281367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24281367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.karkkainen.2000.153">Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">25</span>:153–9.</span> [<a href="/pubmed/10835628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10835628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.karkkainen.2001.12677">Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:12677–82.</span> [<a href="/pmc/articles/PMC60113/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC60113</span></a>] [<a href="/pubmed/11592985" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11592985</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.makhoul.2002.823">Makhoul IR, Sujov P, Ghanem N, Bronshtein M. Prenatal diagnosis of Milroy's primary congenital lymphedema. <span><span class="ref-journal">Prenat Diagn. </span>2002;<span class="ref-vol">22</span>:823–6.</span> [<a href="/pubmed/12224079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12224079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.maldonado.2008.375">Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. <span><span class="ref-journal">Chest. </span>2008;<span class="ref-vol">134</span>:375–81.</span> [<a href="/pubmed/18403655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18403655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.milroy.1892.505">Milroy WF. An undescribed variety of hereditary oedema. <span><span class="ref-journal">NY Med J. </span>1892;<span class="ref-vol">56</span>:505–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.nonne.1891">Nonne M. Vier Falle von Elephantiasis congenita hereditaria. <em>Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin.</em> Berlin, Germany;1891:189-96.</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.ostergaard.2012.356">Ostergaard P, Simpson MA, Mendola A, Vasudevan P, Connell FC, van Impel A, Moore AT, Loeys BL, Ghalamkarpour A, Onoufriadis A, Martinez-Corral I, Devery S, Leroy JG, van Laer L, Singer A, Bialer MG, McEntagart M, Quarrell O, Brice G, Trembath RC, Schulte-Merker S, Makinen T, Vikkula M, Mortimer PS, Mansour S, Jeffery S. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2012;2012;<span class="ref-vol">90</span>:356–62.</span> [<a href="/pmc/articles/PMC3276660/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276660</span></a>] [<a href="/pubmed/22284827" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22284827</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="milroy.REF.sybert.2004.1227">Sybert VP, McCauley E. Turner's syndrome. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">351</span>:1227–38.</span> [<a href="/pubmed/15371580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15371580</span></a>]</div></li></ul></div></div><div id="milroy.Chapter_Notes"><h2 id="_milroy_Chapter_Notes_">Chapter Notes</h2><div id="milroy.Author_History"><h3>Author History</h3><p>Glen W Brice, RGN BSc (Hons) (2005-present)<br />Fiona Connell, MBChB, MRCPCH, MD (2009-present)<br />Steve Jeffery, PhD (2005-present)<br />Sahar Mansour, FRCP (2005-present)<br />Peter Mortimer, MD, FRCP (2005-present)<br />Pia Ostergaard, PhD (2009-present)<br />Carolyn Sholto-Douglas-Vernon, PhD; University of London (2005-2009)</p></div><div id="milroy.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 July 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 April 2007 (gb) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and prenatal testing clinically available</div></li><li class="half_rhythm"><div>27 April 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>19 July 2005 (gb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1239</span><span class="label">PMID: <a href="/pubmed/20301417" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301417</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/anophthalmia-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kss/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1239&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1239/?report=reader">PubReader</a></li><li><a href="/books/NBK1239/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1239" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1239" style="display:none" title="Cite this Page"><div class="bk_tt">Brice GW, Mansour S, Ostergaard P, et al. Milroy Disease. 2006 Apr 27 [Updated 2014 Sep 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1239/pdf/Bookshelf_NBK1239.pdf">PDF version of this page</a> (418K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#milroy.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#milroy.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#milroy.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#milroy.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#milroy.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#milroy.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#milroy.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#milroy.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#milroy.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#milroy.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#milroy.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2324[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLT4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1482570" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1482570" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1482570" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1482570" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301630" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lymphedema-Distichiasis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lymphedema-Distichiasis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mansour S, Brice GW, Jeffery S, Mortimer P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301543" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Bruckner AL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16965327" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.</a><span class="source">[Clin Genet. 2006]</span><div class="brieflinkpop offscreen_noflow">Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ghalamkarpour A, Morlot S, Raas-Rothschild A, Utkus A, Mulliken JB, Boon LM, Vikkula M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Genet. 2006 Oct; 70(4):330-5. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301481" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17458866" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel VEGFR3 mutation causes Milroy disease.</a><span class="source">[Am J Med Genet A. 2007]</span><div class="brieflinkpop offscreen_noflow">A novel VEGFR3 mutation causes Milroy disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Butler MG, Dagenais SL, Rockson SG, Glover TW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2007 Jun 1; 143A(11):1212-7. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301417" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301417" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04159e39a66ee2ba0c843d">Milroy Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Milroy Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:06:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BB8AEE041453100000000009C003B&amp;ncbi_session=CE8BB8AEE04159E1_0156SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1239%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1239&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1239/&amp;ncbi_pagename=Milroy Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BB8AEE04159E1_0156SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>